128 related articles for article (PubMed ID: 38127828)
21. Skull Base Chordomas and Chondrosarcomas.
Kremenevski N; Schlaffer SM; Coras R; Kinfe TM; Graillon T; Buchfelder M
Neuroendocrinology; 2020; 110(9-10):836-847. PubMed ID: 32541136
[TBL] [Abstract][Full Text] [Related]
22. [A clinicopathological and immunohistochemical study of 34 cases of chordoma].
Hu Y; Gao Y; Zhang X
Zhonghua Bing Li Xue Za Zhi; 1996 Jun; 25(3):142-4. PubMed ID: 9275666
[TBL] [Abstract][Full Text] [Related]
23. Diffusion-weighted MRI: distinction of skull base chordoma from chondrosarcoma.
Yeom KW; Lober RM; Mobley BC; Harsh G; Vogel H; Allagio R; Pearson M; Edwards MS; Fischbein NJ
AJNR Am J Neuroradiol; 2013 May; 34(5):1056-61, S1. PubMed ID: 23124635
[TBL] [Abstract][Full Text] [Related]
24. Skull base chordoma and chondrosarcoma: influence of clinical and demographic factors on prognosis: a SEER analysis.
Bohman LE; Koch M; Bailey RL; Alonso-Basanta M; Lee JY
World Neurosurg; 2014 Nov; 82(5):806-14. PubMed ID: 25009165
[TBL] [Abstract][Full Text] [Related]
25. MRI evaluation of sacral chordoma treated with carbon ion radiotherapy alone.
Preda L; Stoppa D; Fiore MR; Fontana G; Camisa S; Sacchi R; Ghitti M; Viselner G; Fossati P; Valvo F; Vitolo V; Bonora M; Iannalfi A; Vischioni B; Vai A; Mastella E; Baroni G; Orecchia R
Radiother Oncol; 2018 Aug; 128(2):203-208. PubMed ID: 29279241
[TBL] [Abstract][Full Text] [Related]
26. Differentiation of skull base chordomas from chondrosarcomas by diffusion-weighted MRI.
Freeze BS; Glastonbury CM
AJNR Am J Neuroradiol; 2013 Oct; 34(10):E113. PubMed ID: 23945231
[No Abstract] [Full Text] [Related]
27. A radiomic nomogram based on an apparent diffusion coefficient map for differential diagnosis of suspicious breast findings.
Hu B; Xu K; Zhang Z; Chai R; Li S; Zhang L
Chin J Cancer Res; 2018 Aug; 30(4):432-438. PubMed ID: 30210223
[TBL] [Abstract][Full Text] [Related]
28. Carbon ion radiotherapy for chordomas and low-grade chondrosarcomas of the skull base. Results in 67 patients.
Schulz-Ertner D; Nikoghosyan A; Thilmann C; Haberer T; Jäkel O; Karger C; Scholz M; Kraft G; Wannenmacher M; Debus J
Strahlenther Onkol; 2003 Sep; 179(9):598-605. PubMed ID: 14628125
[TBL] [Abstract][Full Text] [Related]
29. D2-40 functions as an effective chondroid marker distinguishing true chondroid tumors from chordoma.
Huse JT; Pasha TL; Zhang PJ
Acta Neuropathol; 2007 Jan; 113(1):87-94. PubMed ID: 17021752
[TBL] [Abstract][Full Text] [Related]
30. Apparent diffusion coefficient measurement in glioma: Influence of region-of-interest determination methods on apparent diffusion coefficient values, interobserver variability, time efficiency, and diagnostic ability.
Han X; Suo S; Sun Y; Zu J; Qu J; Zhou Y; Chen Z; Xu J
J Magn Reson Imaging; 2017 Mar; 45(3):722-730. PubMed ID: 27527072
[TBL] [Abstract][Full Text] [Related]
31. CT radiomics-based machine learning classification of atypical cartilaginous tumours and appendicular chondrosarcomas.
Gitto S; Cuocolo R; Annovazzi A; Anelli V; Acquasanta M; Cincotta A; Albano D; Chianca V; Ferraresi V; Messina C; Zoccali C; Armiraglio E; Parafioriti A; Sciuto R; Luzzati A; Biagini R; Imbriaco M; Sconfienza LM
EBioMedicine; 2021 Jun; 68():103407. PubMed ID: 34051442
[TBL] [Abstract][Full Text] [Related]
32. The diagnostic value of magnetic resonance imaging-based texture analysis in differentiating enchondroma and chondrosarcoma.
Cilengir AH; Evrimler S; Serel TA; Uluc E; Tosun O
Skeletal Radiol; 2023 May; 52(5):1039-1049. PubMed ID: 36434265
[TBL] [Abstract][Full Text] [Related]
33. Chondroid chordoma--a variant of chordoma. A morphologic and immunohistochemical study.
Rosenberg AE; Brown GA; Bhan AK; Lee JM
Am J Clin Pathol; 1994 Jan; 101(1):36-41. PubMed ID: 7506477
[TBL] [Abstract][Full Text] [Related]
34. Combined radiotherapy and razoxane in the treatment of chondrosarcomas and chordomas.
Rhomberg W; Eiter H; Böhler F; Dertinger S
Anticancer Res; 2006; 26(3B):2407-11. PubMed ID: 16821624
[TBL] [Abstract][Full Text] [Related]
35. Challenges of local recurrence and cure in low grade malignant tumors of the spine.
Boriani S; Saravanja D; Yamada Y; Varga PP; Biagini R; Fisher CG
Spine (Phila Pa 1976); 2009 Oct; 34(22 Suppl):S48-57. PubMed ID: 19829277
[TBL] [Abstract][Full Text] [Related]
36. Kinase Activity in Recurring Primary Skull Base Chordomas and Chondrosarcomas: Identification of Novel Pathways of Oncogenesis and Potential Drug Targets.
Tatman PD; Osbun J; Yakkioui Y; Kaur S; Parada C; Busald T; Born D; Ahmad O; Zhang J; Ferreira M
World Neurosurg; 2017 Nov; 107():75-81. PubMed ID: 28647652
[TBL] [Abstract][Full Text] [Related]
37. Role of the Apparent Diffusion Coefficient as a Predictor of Tumor Progression in Patients with Chordoma.
Sasaki T; Moritani T; Belay A; Capizzano AA; Sato SP; Sato Y; Kirby P; Ishitoya S; Oya A; Toda M; Takahashi K
AJNR Am J Neuroradiol; 2018 Jul; 39(7):1316-1321. PubMed ID: 29724767
[TBL] [Abstract][Full Text] [Related]
38. Radiomics analysis of apparent diffusion coefficient in cervical cancer: A preliminary study on histological grade evaluation.
Liu Y; Zhang Y; Cheng R; Liu S; Qu F; Yin X; Wang Q; Xiao B; Ye Z
J Magn Reson Imaging; 2019 Jan; 49(1):280-290. PubMed ID: 29761595
[TBL] [Abstract][Full Text] [Related]
39. Radiosurgery for cranial base chordomas and chondrosarcomas.
Krishnan S; Foote RL; Brown PD; Pollock BE; Link MJ; Garces YI
Neurosurgery; 2005 Apr; 56(4):777-84; discussion 777-84. PubMed ID: 15792516
[TBL] [Abstract][Full Text] [Related]
40. Loss of heterozygosity in the retinoblastoma tumor suppressor gene in skull base chordomas and chondrosarcomas.
Eisenberg MB; Woloschak M; Sen C; Wolfe D
Surg Neurol; 1997 Feb; 47(2):156-60; discussion 160-1. PubMed ID: 9040820
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
